827 related articles for article (PubMed ID: 25614195)
1. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
[TBL] [Abstract][Full Text] [Related]
2. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513
[TBL] [Abstract][Full Text] [Related]
3. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension.
Gospe SM; Bhatti MT; El-Dairi MA
Br J Ophthalmol; 2016 Apr; 100(4):505-9. PubMed ID: 26269534
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension.
Skau M; Yri H; Sander B; Gerds TA; Milea D; Jensen R
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):567-74. PubMed ID: 22592348
[TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema.
Huang-Link Y; Eleftheriou A; Yang G; Johansson JM; Apostolou A; Link H; Jin YP
Eur J Neurol; 2019 May; 26(5):808-e57. PubMed ID: 30586220
[TBL] [Abstract][Full Text] [Related]
6. Optic Nerve Head Volumetry by Optical Coherence Tomography in Papilledema Related to Idiopathic Intracranial Hypertension.
Dreesbach M; Joachimsen L; Küchlin S; Reich M; Gross NJ; Brandt AU; Schuchardt F; Harloff A; Böhringer D; Lagrèze WA
Transl Vis Sci Technol; 2020 Feb; 9(3):24. PubMed ID: 32742754
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension.
Eren Y; Kabatas N; Guven H; Comoglu S; Gurdal C
Acta Neurol Belg; 2019 Sep; 119(3):351-357. PubMed ID: 30120685
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.
Albrecht P; Blasberg C; Ringelstein M; Müller AK; Finis D; Guthoff R; Kadas EM; Lagreze W; Aktas O; Hartung HP; Paul F; Brandt AU; Methner A
J Neurol; 2017 Jul; 264(7):1370-1380. PubMed ID: 28584914
[TBL] [Abstract][Full Text] [Related]
9. Correlation Between Optic Disc Peripapillary Capillary Network and Papilledema Grading in Patients With Idiopathic Intracranial Hypertension: A Study of Optical Coherence Tomography Angiography.
Rodriguez Torres Y; Lee P; Mihlstin M; Tomsak RL
J Neuroophthalmol; 2021 Mar; 41(1):48-53. PubMed ID: 31972713
[TBL] [Abstract][Full Text] [Related]
10. Effect of optic nerve sheath fenestration for idiopathic intracranial hypertension on retinal nerve fiber layer thickness.
Starks V; Gilliland G; Vrcek I; Gilliland C
Orbit; 2016; 35(2):87-90. PubMed ID: 26928128
[TBL] [Abstract][Full Text] [Related]
11. Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension.
Aojula A; Mollan SP; Horsburgh J; Yiangou A; Markey KA; Mitchell JL; Scotton WJ; Keane PA; Sinclair AJ
BMC Ophthalmol; 2018 Jan; 17(1):257. PubMed ID: 29298687
[TBL] [Abstract][Full Text] [Related]
12. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
;
Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807
[TBL] [Abstract][Full Text] [Related]
13. High-Resolution Imaging of the Optic Nerve and Retina in Optic Nerve Hypoplasia.
Pilat A; Sibley D; McLean RJ; Proudlock FA; Gottlob I
Ophthalmology; 2015 Jul; 122(7):1330-9. PubMed ID: 25939636
[TBL] [Abstract][Full Text] [Related]
14. Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension.
Vijay V; Mollan SP; Mitchell JL; Bilton E; Alimajstorovic Z; Markey KA; Fong A; Walker JK; Lyons HS; Yiangou A; Tsermoulas G; Brock K; Sinclair AJ
JAMA Ophthalmol; 2020 Dec; 138(12):1264-1271. PubMed ID: 33090189
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography.
Rebolleda G; Muñoz-Negrete FJ
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5197-200. PubMed ID: 19011007
[TBL] [Abstract][Full Text] [Related]
16. Repeatability of peripapillary retinal nerve fiber layer and inner retinal thickness among two spectral domain optical coherence tomography devices.
Matlach J; Wagner M; Malzahn U; Göbel W
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6536-46. PubMed ID: 25228545
[TBL] [Abstract][Full Text] [Related]
17. OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension.
Waisbourd M; Leibovitch I; Goldenberg D; Kesler A
Clin Neurol Neurosurg; 2011 Dec; 113(10):839-43. PubMed ID: 21700384
[TBL] [Abstract][Full Text] [Related]
18. Quantification of peripapillary total retinal volume in pseudopapilledema and mild papilledema using spectral-domain optical coherence tomography.
Fard MA; Fakhree S; Abdi P; Hassanpoor N; Subramanian PS
Am J Ophthalmol; 2014 Jul; 158(1):136-43. PubMed ID: 24727146
[TBL] [Abstract][Full Text] [Related]
19. Detection of glaucomatous progression by spectral-domain optical coherence tomography.
Na JH; Sung KR; Lee JR; Lee KS; Baek S; Kim HK; Sohn YH
Ophthalmology; 2013 Jul; 120(7):1388-95. PubMed ID: 23474248
[TBL] [Abstract][Full Text] [Related]
20. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.
; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith M; Sibony P; Plumb K; Wang JK; Werner JS
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8180-8. PubMed ID: 25370510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
